U.S. Software Stock News

If you are wondering whether Brookfield Infrastructure Partners is attractively priced or not, you are in the right place. The units currently trade at US$35.14, with returns of 2.4% year to date and 13.0% over the last year. This may signal that investors are reassessing both the upside and the risks. Recent news coverage has focused on Brookfield Infrastructure Partners as a global owner and operator of essential assets. This can shape how investors think about its resilience and cash flow...

Limbach Holdings, Inc. recently appointed long-time leaders Nick Angerosa as Executive Vice President, National Customer Solutions, and Jay Sharp as Executive Vice President, Sales, effective January 13, 2026, formalizing their expanded roles after years of regional leadership within the company. The elevation of two deeply tenured insiders to focus on customer solutions and sales execution highlights Limbach’s emphasis on strengthening owner-direct relationships and aligning commercial...

Indivior Pharmaceuticals, Inc. recently completed its move of corporate headquarters to the US, creating a new Delaware-based parent while closing a prior US$80.46 million ESOP-related shelf registration and filing a new US$569.10 million ESOP-focused shelf for common stock. This restructuring not only concentrates governance and financing in the company’s largest market but also simplifies reporting, lending arrangements and future equity-based employee programs. We will examine how...

Vaxart, Inc. recently reported in npj Vaccines that its double-blind, placebo-controlled Phase 1 trial of a single-dose oral bivalent norovirus vaccine in breastfeeding women showed vaccine-induced functional norovirus-specific antibodies in maternal breastmilk and serum, as well as norovirus-specific IgA in the stool of their breastfed infants, with the vaccine remaining safe and well tolerated. The finding of a positive correlation between breast milk IgA levels and infant stool IgA offers...

In recent days, Antero Resources has drawn attention as heavy call-option trading coincided with reports that Winter Storm Fern could disrupt US natural gas production and pipeline operations. Investor interest has also been reinforced by insider share purchases and ongoing analyst coverage, underscoring how short-term weather risks can quickly reshape sentiment toward natural gas producers. We’ll now examine how this options surge against the backdrop of Winter Storm Fern could shape...

Callaway Golf (CALY) is back in focus after launching its Quantum line of clubs and reintroducing itself under a refreshed corporate name and ticker. Together, these changes reshape how investors may view the business. See our latest analysis for Callaway Golf. Those product launches and the refreshed Callaway Golf identity come after a strong run in the shares, with a 30 day share price return of 31.01% and a 1 year total shareholder return of 90.82%, even though the 3 year and 5 year total...

Earlier this year, H.C. Wainwright reiterated a positive rating on Kodiak Sciences, expressing confidence in upcoming clinical trial readouts for its retinal disease candidates tarcocimab and KSI-101, following the company’s approximately US$184,000,000 capital raise. The combination of anticipated Phase 3 and Phase 1b data and strengthened funding highlights how Kodiak is positioning its biopolymer platform to potentially reduce treatment burden in conditions like wet age-related macular...

Citizens Community Bancorp (CZWI) just capped FY 2025 with fourth quarter revenue of US$15.6 million and EPS of US$0.44, while trailing 12 month revenue stood at US$60.4 million and EPS at US$1.46. Over recent periods, quarterly revenue has ranged from US$14.4 million to US$15.6 million and quarterly EPS from roughly US$0.32 to US$0.44, giving investors a clear view of how the earnings run rate has evolved into the current trailing 12 month profile. With net profit margins holding in the mid...

If you are wondering whether Sinclair at around US$15.24 is a bargain or a value trap, you are in the right place for a clear look at what the current price actually reflects. Over the past year the stock has returned 9.9%, while its 3 year and 5 year returns of 7.4% and 38.0% declines show a much tougher longer term picture that may have shifted how investors view its risk and potential. Recent coverage has focused on Sinclair's position in the US media space, including ongoing attention on...

Hycroft Mining Holding (NasdaqCM:HYMC) reported the highest grades of silver identified to date at its Nevada operation, with drilling indicating resource continuity in all directions and at depth. The company advanced a significant SEC shelf registration, which may allow it to raise capital more flexibly in the future. These updates arrive as silver and gold prices trade around historic highs, drawing fresh attention to Hycroft’s asset base and funding options. Hycroft Mining focuses on...

Riot Platforms recently held a special call to outline a series of transformative transactions that advance its rapidly scaling data center operations, including an AI-focused lease agreement with AMD and new Texas infrastructure initiatives alongside its Bitcoin mining business. This move marks a meaningful repositioning of Riot from a pure-play Bitcoin miner toward a broader role as an infrastructure provider for artificial intelligence and high-performance computing workloads. Next, we...

If you are wondering whether 3M's current share price really reflects its underlying worth, this article walks through the key numbers so you can judge the value story for yourself. 3M's share price last closed at US$159.52, with returns of 4.9% decline over 7 days, 1.6% decline over 30 days, 1.4% decline year to date, 7.3% over 1 year, 89.5% over 3 years and 31.3% over 5 years. These figures give useful context for any valuation check you are considering. Recent news around 3M has focused...

First BanCorp (NYSE:FBP) has announced an 11% increase in its quarterly cash dividend. The change reflects the bank's current financial position and focus on returning cash to shareholders. This dividend adjustment is a material event for income focused investors tracking the stock. First BanCorp, a financial services company operating under the NYSE:FBP ticker, is closely watched by investors who care about income and capital stability. Dividend moves often draw attention because they...

If you are wondering whether Ardelyx shares still offer value at around US$7.80, you are not alone. The recent price action has put the stock firmly on many watchlists. The share price sits at US$7.80 after returns of 15.6% over 7 days, 35.9% over 30 days, 26.8% year to date, 42.6% over 1 year and a very large gain over 3 years, with 12.1% over 5 years also adding context. Recent headlines around Ardelyx have focused on its position in the pharmaceuticals and biotech space and ongoing...

FFB Bancorp (FFBB) just wrapped up FY 2025 with fourth quarter revenue of US$19.4 million and basic EPS of US$1.08, setting the tone for how the full year is being assessed. Over recent quarters, revenue has moved from US$26.6 million in Q4 2024 to US$27.3 million in Q1 2025, US$24.2 million in Q2 2025 and US$22.8 million in Q3 2025, while quarterly EPS shifted from US$3.06 to US$2.56, US$1.95 and US$2.07 across the same stretch. Taken together with the latest trailing 12 month totals, these...

United Bankshares (NasdaqGS:UBSI) reported record earnings for 2025, supported by its acquisition of Piedmont Bancorp. The company completed the integration of Piedmont Bancorp, adding to its banking footprint and customer base. United Bankshares also finished a substantial share repurchase program, signaling a focus on returning capital to shareholders. United Bankshares operates as a regional banking group, providing lending, deposit, and related financial services to consumers and...

Paychex (NasdaqGS:PAYX) has appointed J. Michael Hansen, former Cintas CFO, to its Board of Directors as an independent director. The move expands the Paychex board and brings additional financial and leadership experience from a veteran executive in related industries. For investors watching Paychex at a current share price of $106.19, the board expansion arrives after a 26.0% decline over the past year and a 7.0% decline over the past 30 days. Over longer periods, the stock shows a 36.0%...

If you are wondering whether Alexandria Real Estate Equities is attractively priced right now, starting with a clear view of its valuation can help you frame that decision. The share price recently closed at US$57.16, with a 17.6% gain over 30 days, a 16.7% return year to date, but a 40.4% decline over 1 year that sits alongside 57.7% and 58.6% declines over 3 and 5 years. These moves sit against a backdrop of ongoing interest in listed real estate and changing sentiment toward specialized...

CorMedix overview and recent share performance CorMedix (CRMD) has drawn investor attention after a sharp pullback over the past month, with the share price down about 38% and roughly 30% lower over the past 3 months. That recent weakness comes despite a 1 day return of 6.74% and a 14.45% move over the past week. This may prompt some investors to reassess how the current price compares with the company’s fundamentals. See our latest analysis for CorMedix. Looking beyond the recent bounce,...

Peoples Bancorp of North Carolina (PEBK) just closed out FY 2025 with fourth quarter revenue of US$24.6 million and EPS of US$1.25, alongside trailing 12 month revenue of US$89.1 million and EPS of US$3.74 that reflects 21.3% earnings growth over the past year. Over recent periods, the company has seen quarterly revenue move from US$21.1 million in Q4 2024 to US$24.6 million in Q4 2025, while quarterly EPS shifted from US$0.67 to US$1.25. This sets up a story where improving margins and a...

U.S. Gold Corp recently advanced its CK Gold Project in Wyoming toward a Definitive Feasibility Study after securing US$31,000,000 in financing, while benefiting from record-high gold prices that enhance project economics and the perceived value of its Nevada and Idaho exploration assets. An interesting angle is how stronger gold prices can make mine-construction financing more attainable, potentially accelerating timelines for turning U.S.-based mineral resources into producing...

If you are wondering whether BridgeBio Pharma's share price still makes sense after a strong run, this article focuses on what the numbers say about value rather than the excitement around the stock. The stock trades at US$77.81, with returns of 2.0% over the past week, 2.7% over the past month, a slight year to date decline of 0.5%, a 112.2% return over the past year, a very large 3 year gain that is around 7x, and a 35.5% return over 5 years. Recent news around BridgeBio has centered on...

Dynex Capital (DX) has wrapped up FY 2025 with Q4 total revenue of US$202.0 million and basic EPS of US$1.17, alongside trailing twelve month revenue of US$372.1 million and EPS of US$2.49. This sits next to a very large 190.8% earnings jump over the past year and an 11.4% annual earnings decline over five years. The company has seen quarterly revenue move from US$60.3 million in Q4 2024 to US$201.997 million in Q4 2025, while basic EPS shifted from US$0.61 to US$1.17 over the same period...

After a strong run, you might be wondering whether Karooooo is still reasonably priced or starting to look stretched at current levels. The stock last closed at US$50.84, with returns of 8.6% over the past week, 7.3% over the last month, 13.8% year to date, and 19.6% over the past year. This puts recent price action front and center for anyone thinking about value. Over the past three years, Karooooo has delivered a total return of 122.8%, which gives useful context to the shorter term moves...